--- title: "(NU/1850) The Provision of Metabolomic Analysis Services (AbsolutelDQ Bile Acids kit and MxP Quant 500 Kits) for the NASH-DTA Retrospective and Prospective Study" ocid: "ocds-h6vhtk-039679" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-039679" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-039679.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-039679.json" source: "Find A Tender Service" current_stage: "Tender" buyer: "NEWCASTLE UNIVERSITY" published: "2023-01-11" --- # (NU/1850) The Provision of Metabolomic Analysis Services (AbsolutelDQ Bile Acids kit and MxP Quant 500 Kits) for the NASH-DTA Retrospective and Prospective Study Buyer: NEWCASTLE UNIVERSITY Current stage: Tender OCID: ocds-h6vhtk-039679 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-039679) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-039679.json) ## Summary The Newcastle University is looking to engage a supplier for the provision of Metabolomic Analysis Services for the NASH-DTA Retrospective and Prospective Study. This tender falls under the 'Research services' category in the services industry. The contracting authority, Newcastle University, based in Newcastle, United Kingdom, has set the tender deadline for 13th February 2023. The procurement method used is an Open Procedure, and the contract period is 2160 days. This tender from Newcastle University offers opportunities for businesses specializing in research laboratory services to participate in cutting-edge biomedical research projects. Companies that provide metabolomic analysis services and have experience in biomarker development for diseases like NAFLD would be well-suited to compete. The opportunity is open for both existing suppliers and new entrants to the market who can fulfil the requirements outlined in the tender specifications. ## Notice The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the "NASH Disease Translational Accelerator" (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression. The NASH-DTA project has two parts: retrospective and prospective study. Retrospective study is based on analysing existing samples, prospective study will recruit 200 patients and collect new samples over 5 years. The purpose of this tender process is to engage a supplier to provide metabolomic analysis on plasma samples from both a retrospective and prospective study using AbsolutelDQ Bile Acids kit and MxP Quant 500 Kit. ### Lot Information Lot 1 The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences. Its members map across the biomedical research landscape. A number of major research projects are led from within the Institute including the "NASH Disease Translational Accelerator" (NASH-DTA) project. This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD). Their common goals are developing, validating and qualifying better biomarkers for NAFLD. Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression. Biomarkers under investigation in the project include genes that contribute to NAFLD progression. The NASH-DTA project has two parts: retrospective and prospective study. Retrospective study is based on analysing existing samples, prospective study will recruit 200 patients and collect new samples over 5 years. The purpose of this tender process is to engage a supplier to provide metabolomic analysis on plasma samples from both a retrospective and prospective study using AbsolutelDQ Bile Acids kit and MxP Quant 500 Kit. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/000774-2023 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 11 Jan 2023 | | Submission deadline | 13 Feb 2023 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £388,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NEWCASTLE UNIVERSITY | | Locality | NEWCASTLE | | Post town | Newcastle upon Tyne | | Postcode | NE1 7RU | | Country | England | | ITL 1 | TLC North East (England) | | ITL 2 | TLC4 Northumberland, Durham and Tyne & Wear | | ITL 3 | TLC43 Tyneside | | Local authority | Newcastle upon Tyne | | Electoral ward | Monument | | Westminster constituency | Newcastle upon Tyne Central and West | | Delivery location | TLC22 Tyneside | ## CPV Codes ### Divisions - 73 - Research and development services and related consultancy services ### Codes - 73110000 - Research services - 73111000 - Research laboratory services ## Release History - 11 Jan 2023 at 10:34 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/000774-2023 ## Notice URLs - https://procontract.due-north.com/ - https://www.ncl.ac.uk ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-039679. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-039679.json.